Cargando…
Human physiologically based pharmacokinetic model for ACE inhibitors: ramipril and ramiprilat
BACKGROUND: The angiotensin-converting enzyme (ACE) inhibitors have complicated and poorly characterized pharmacokinetics. There are two binding sites per ACE (high affinity "C", lower affinity "N") that have sub-nanomolar affinities and dissociation rates of hours. Most inhibito...
Autores principales: | Levitt, David G, Schoemaker, Rik C |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1373666/ https://www.ncbi.nlm.nih.gov/pubmed/16398929 http://dx.doi.org/10.1186/1472-6904-6-1 |
Ejemplares similares
-
Simultaneous Determination and Pharmacokinetic Study of Losartan, Losartan Carboxylic Acid, Ramipril, Ramiprilat, and Hydrochlorothiazide in Rat Plasma by a Liquid Chromatography/Tandem Mass Spectrometry Method
por: Dubey, Ramkumar, et al.
Publicado: (2015) -
Lack of Male-Female Differences in Disposition and Esterase Hydrolysis of Ramipril to Ramiprilat in Healthy Volunteers after a Single Oral Dose
por: Vree, Tom B., et al.
Publicado: (2003) -
Human physiologically based pharmacokinetic model for propofol
por: Levitt, David G, et al.
Publicado: (2005) -
Effect of ramipril on kidney, lung and heart ACE2 in a diabetic mice model
por: Vergara, Ander, et al.
Publicado: (2021) -
Effects of Ramiprilat-Coated Stents on Neointimal Hyperplasia, Inflammation, and Arterial Healing in a Porcine Coronary Restenosis Model
por: Hong, Young Joon, et al.
Publicado: (2011)